Posted by Michael Wonder on 11 Jan 2017
AbbVie vows to keep drug price increases below 10%
11 January 2017 - AbbVie Chief Executive Richard Gonzalez on Wednesday promised to keep all drug price increases in 2017 under 10%, becoming the third global drugmaker to publicly make that pledge.
Speaking at the annual JP Morgan Healthcare Conference in San Francisco, Gonzalez said his company would raise prices just once this year, and the percentage increases would not exceed single digits.
AbbVie, whose rheumatoid arthritis treatment Humira is the world's biggest-selling drug, joins Allergan and Danish diabetes company Novo Nordisk as the first major drug makers promising such a limit on price increases.
